0 item $0.00

Preclinical Disease and Prevention

Reducing the risk of complications from cardiometabolic disease.

Read more

Laboratory head

Close
i Profile of author
Associate Professor Melinda Carrington

Fellow of the Filippo and Maria Casella Cardiology Centre of Excellence

Phone:+61 3 8532 1638

Latest Achievements

European Society of Cardiology Heart Failure, Late breaking science award (2017)

European Society of Cardiology, Late breaking science award (2015)

European Society of Cardiology Heart Failure, Late breaking science award (2014)

American Heart Association, Late breaking trial (2014)

American Heart Association, Best research paper (2013)

Read full biography
Associate Professor Melinda Carrington Fellow of the Filippo and Maria Casella Cardiology Centre of Excellence
Focused on supporting individuals to reduce their risk of complications from cardiometabolic disease.

 

About Preclinical Disease and Prevention

The Preclinical Disease and Prevention unit is devoted to helping people identify and address their risk of developing or managing two of Australia’s most prevalent chronic diseases — cardiovascular disease and diabetes. The research of the Preclinical Disease and Prevention unit occurs mainly in community settings with a focus on those identified as being at the highest risk for developing cardiometabolic disease or having a recurrent event or hospitalisation.

The Preclinical Disease and Prevention unit conducts clinical trial research to demonstrate the benefits of nurse-facilitated models of care which implement digital delivery of health care (“mHealth”). Integral to this work is nurse coaching and liaison with health professionals to provide personalised care and promote health behaviour change.

We collaborate with eminent cardiologists, endocrinologists, leading GP academics and Aboriginal health researchers. These partnerships, combined with the unit’s expert team of research fellows, clinical researchers, nurses and technical and administrative support staff enable the Unit to carry out innovative research for enhancing the detection and improving the management of cardiometabolic disease.

Research focus

  • Clinical trials of disease management programs for primary and secondary prevention of cardiometabolic disease.
  • Establishing the evidence for nurse-led models of care.
  • Implementing digital delivery (mHealth) of health care.
  • Risk detection and surveillance using a combination of traditional and novel risk indicators.
  • Mass data analyses of primary care management of cardiometabolic risk.

Support us

With the rising number of Australians affected by diabetes, heart disease and stroke, the need for research is more critical than ever.

Find out more